At the heart of Smilow Cancer Hospital and Yale Cancer Center, our commitment to safety, compassionate care, and research excellence will always remain.
Patient and Cancer Information
Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute- and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.
The delivery of cancer care is becoming ever more complex, involving multiple disciplines for the diagnosis and treatment of patients. In response, Smilow Cancer Hospital and Yale Cancer Center have developed 13 multidisciplinary clinical centers to care for patients diagnosed with cancer. The clinical centers allow physicians and specialists at Smilow Cancer Hospital to focus their expertise on specific types of cancers enabling them to provide superior care to our patients through a patient-friendly system of care led by a nurse coordinator. Our nationally recognized physicians provide unparalleled cancer expertise and are leaders in both the treatment of cancers and the development of innovative treatment strategies.
The key characteristics of the 13 Clinical Centers at Smilow Cancer Hospital are:
- Patient centered care
- Rapid access to appointments and relevant tests
- Personalized care led by a physician in collaboration with a team of specialists
- Personal communication and assistance from a dedicated intake specialist and nurse coordinator
- Compassion and support for the psychological aspects of cancer
- Rapid communication with and involvement of outside primary care and referring physicians
Ways to stay safe during chemotherapy and immunotherapy.
Latest News
- October 11, 2024Source: Cancer Network
Getting to the CAR T-cell Therapy Starting Line With Radiotherapy in R/R DLBCL
- October 10, 2024Source: WTNH News 8
How AI could play a role in detecting breast cancer
- October 10, 2024
Unraveling the Metabolic Landscape of Colorectal Cancer
- October 10, 2024Source: The Guardian
‘My cancer was not in those pictures’: how breast density affects mammograms
- October 09, 2024Source: Yale News
Six Yale Researchers Receive NIH ‘High-Risk, High-Reward’ Awards
- October 09, 2024
Hyundai Hope on Wheels Grant Provides $100K for Childhood Cancer Research at Yale
- October 09, 2024
Smilow Cares - Cannabis in Cancer Care: A Historical Overview and Current Perspectives
- October 09, 2024
Yale Professors Awarded $1.9 Million Grant for Gene Expression Research
- October 08, 2024Source: Yale News
Study sheds light on proteins linked to congenital developmental disorders
- October 08, 2024Source: Hartford Courant
A CT woman helps her granddaughter handle life-altering disease. ‘Take the mess and make a message’
- October 08, 2024Source: Essence
Why Black Women Are At Greater Risk Of Dying From Breast Cancer, Even When It’s Treatable
- October 07, 2024
CAR T-Cell Therapy: Pathology Is Key to This Revolutionary Cancer Treatment